Inhibiting 15-PGDH blocks blood–brain barrier deterioration and protects mice from Alzheimer’s disease and traumatic brain injury

Proceedings of the National Academy of Sciences, Volume 122, Issue 21, May 2025.
SignificanceKoh et al. show that 15-hydroxyprostaglandin dehydrogenase (15-PGDH) is pathologically elevated in human and mouse Alzheimer’s disease (AD), traumatic brain injury (TBI), and aging, with 15-PGDH localized to myeloid cells of the blood–brain …
Read More

Related posts

How Nigerians can buy Dangote Refinery as company submits applications

China to tighten entry and exit regulations for travellers from Sept 15 , China News

The Hydrogen Stream: Commissioning begins for 2.2 GW Neom H2 project in Saudi Arabia